4 Super Stocks I’d Buy With £10,000

GlaxoSmithKline plc (LON:GSK), BHP Billiton plc (LON:BLT), HSBC Holdings plc (LON:HSBA) and easyJet plc (LON:EZJ) are four top-notch companies.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

An investors’ total return is made up of capital gains and income. Most investors, of course, tend to focus on one or the other. However, there are companies out there that offer a potent mix of both income and the potential for capital gains. Here are four that do so and, as such, could be worth investing in.

GlaxoSmithKline

GlaxoSmithKline’s (LSE: GSK) (NYSE: GSK.US) update this week showed that the company continues to struggle from the effects of generic competition, while its share price has been subdued at least partly because of bribery allegations in China. However, GlaxoSmithKline has vast potential, with the company having an enviable pipeline of drugs that should propel earnings numbers upwards over the long run. Having sold off consumer brands such as Lucozade and Ribena, the company is now free to focus on drug development and, with shares trading on a price to earnings (P/E) ratio of just 13.1, they offer good value at current levels. Meanwhile, a yield of 5.5% is highly attractive and is well above the FTSE 100’s yield of 3.4%.

HSBC

HSBC (LSE: HSBA) continues to offer investors top-notch income and growth potential. Indeed, the bank is forecast to grow its bottom line by 9% in each of the next two years, while its yield of 4.9% is not only highly attractive, it is also set to increase at a brisk pace. That’s because dividend per share growth is expected to be as much as 7.5% next year, meaning shares in HSBC could be yielding 5.3% next year (assuming the share price does not change from its present level). Furthermore, HSBC is well positioned to benefit from a pickup in the macroeconomic outlook for emerging markets and, as a result, could deliver improved growth prospects going forward.

BHP Billiton

Despite experiencing a number of highly challenging years, BHP Billiton (LSE: BLT) has weathered the storm better than many of its mining peers. That’s due to its vast diversification, as well as a sound strategy of mothballing large projects until they become more economically attractive. With the outlook for China continuing to improve, BHP Billiton is well placed to benefit from buoyant demand, while a yield of 3.6% is highly impressive for a mining stock with strong long term growth potential.

easyJet

Shares in easyJet (LSE: EZJ) have been hit by the recent spike in the oil price, as well as disappointment among many investors regarding its profit forecasts. However, easyJet continues to offer growth potential that is superior to that of the wider market, with earnings per share (EPS) expected to increase by 12% in each of the next two years. Combined with a P/E of just 11.7, this makes easyJet’s price to earnings growth (PEG) ratio less than 1, which is highly attractive. In addition, a yield of 2.9% looks set to grow at a brisk pace, as dividends per share are expected to be 12.5% higher next year than this year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of BHP Billiton, GlaxoSmithKline and HSBC Holdings. The Motley Fool recommends GlaxoSmithKline.

More on Investing Articles

Investing Articles

Should I pile into Greatland Gold (GGP) now the share price is just 7.25p?

The Greatland Gold (GGP) share price could take off on the back of "transformational" operational progress, but I'm hesitant.

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

How much can I really make from UK stocks?

This Fool was thrilled to discover a fascinating study on the long-term returns of UK stocks. Here's what it had…

Read more »

Investing Articles

Direct Line shares rocketed 41% yesterday! What now?

Direct Line shares have smashed through the ceiling on news of a takeover bid from another UK insurance giant. Our…

Read more »

Light trails from traffic moving down The Mound in central Edinburgh, Scotland during December
Investing Articles

What are the best value shares for me to buy in December?

Stephen Wright thinks shares in UK companies looking to streamline their operations could be attractive opportunities for value investors next…

Read more »

Young female analyst working at her desk in the office
Investing Articles

Is this FTSE 100 stock really the next Rolls-Royce?

JP Morgan analysts suggest shares in FTSE 100 aerospace manufacturer Melrose could be set for some big gains. Stephen Wright…

Read more »

Investing Articles

This Stocks and Shares ISA plan could reduce my investing stress

Does trying to decide what shares to buy in a Stocks and Shares ISA give you headaches? Maybe there's a…

Read more »

Burst your bubble thumbtack and balloon background
Investing Articles

Is the S&P 500 heading for a correction?

This writer wonders whether the S&P 500 might be due a sharp pullback, based on a recent chance conversation with…

Read more »

Investing Articles

Aged 40? Here’s how skipping the daily coffee could build a £2.4m ISA!

With a tax-efficient Stocks and Shares ISA, UK investors have a chance to build long-term wealth for the price of…

Read more »